The effect of increasing doses of β-agonists on airflow in patients with chronic airflow limitation
- 31 August 1993
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 87 (6) , 433-438
- https://doi.org/10.1016/0954-6111(93)90069-c
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tolerance to ß2-Agonists in Patients with Chronic Obstructive Pulmonary DiseaseChest, 1990
- A Randomized, Controlled Trial of Theophylline in Patients with Severe Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1989
- High dose salbutamol in chronic airflow obstruction: comparison of nebulizer with RotacapsRespiratory Medicine, 1988
- Salbutamol and ipratropium in partially reversible airway obstructionRespiratory Medicine, 1987
- Comparison of Domiciliary Nebulized Salbutamol and Salbutamol From a Metered-dose Inhaler in Stable Chronic Airflow LimitationChest, 1987
- Compliance of patients with asthma with an experimental aerosolized medication: Implications for controlled clinical trialsJournal of Allergy and Clinical Immunology, 1986
- EFFECTS OF PREDNISOLONE IN CHRONIC AIRFLOW LIMITATIONThe Lancet, 1984
- Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.Thorax, 1984
- Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.Thorax, 1983
- A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.Thorax, 1978